Evolent Health, Inc. (EVH)
- Previous Close
29.62 - Open
29.56 - Bid --
- Ask --
- Day's Range
29.33 - 29.73 - 52 Week Range
23.33 - 36.70 - Volume
155,523 - Avg. Volume
941,619 - Market Cap (intraday)
3.364B - Beta (5Y Monthly) 1.54
- PE Ratio (TTM)
-- - EPS (TTM)
-1.28 - Earnings Date May 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
44.67
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
www.evolent.com4,700
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EVH
Performance Overview: EVH
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EVH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EVH
Valuation Measures
Market Cap
3.37B
Enterprise Value
3.83B
Trailing P/E
--
Forward P/E
21.37
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.68
Price/Book (mrq)
3.16
Enterprise Value/Revenue
1.95
Enterprise Value/EBITDA
-154.35
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.76%
Return on Assets (ttm)
0.86%
Return on Equity (ttm)
-10.74%
Revenue (ttm)
1.96B
Net Income Avi to Common (ttm)
-142.26M
Diluted EPS (ttm)
-1.28
Balance Sheet and Cash Flow
Total Cash (mrq)
192.82M
Total Debt/Equity (mrq)
51.74%
Levered Free Cash Flow (ttm)
172.48M
Research Analysis: EVH
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell